Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial - Leenen, F H; Nwachuku, C E; Black, H R; Cushman, W C; Davis, B R; Simpson, L M; Alderman, M H; Atlas, S A; Basile, J N; Cuyjet, A B; Dart, R; Felicetta, J V; Grimm, R H; Haywood, L J; Jafri, S Z; Proschan, M A; Thadani, U; Whelton, P K; Wright, J TAntihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group (Hypertension, 2006)